Dr. David Reardon on Targeting Brain Tumors and Monitoring Resistances

David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses identifying certain characteristics in a patient's brain tumor in order to administer better treatment.

David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses identifying certain characteristics in a patient's brain tumor in order to administer better treatment. Reardon says medical professionals should identify the key drivers in a patient's tumor and select the therapy, or combination therapies, that would best target those traits.